Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Jordan

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Advances in Experimental Medicine and Biology|April 30, 2009
A synthetic peptide approach for elucidating the points of natural auto-antibody reactivity to proteolytic fragments of human IgGA Schmidt, D DeRiggi, R E Jordan, et al.
Biochemical Society Transactions|November 1, 1995
Anti-platelet monoclonal antibodies for the prevention of arterial thrombosis: experience with ReoPro, a monoclonal antibody directed against the platelet GPIIb/IIIa receptorH F Weisman, T F Schaible, R E Jordan, et al.
Advances in Experimental Medicine and Biology|January 1, 1977
Factors affecting the proteolytic degradation of elastinH M Kagan, R E Jordan, R M Lerch, et al.
The Journal of Biological Chemistry|June 25, 1989
Inactivation of human antithrombin by neutrophil elastase. Kinetics of the heparin-dependent reactionR E Jordan, R M Nelson, J Kilpatrick, et al.
American Heart Journal|March 31, 2000
Therapeutic heparin concentrations augment platelet reactivity: implications for the pharmacologic assessment of the glycoprotein IIb/IIIa antagonist abciximabM A Mascelli, N S Kleiman, S J Marciniak, et al.
Hepatology (Baltimore, Md.)|May 1, 1985
The immunologic diagnosis of chronic active "autoimmune" hepatitis: distinction from systemic lupus erythematosusL E Gurian, T M Rogoff, A J Ware, et al.
The American Journal of Medicine|September 11, 1989
Antithrombin inactivation by neutrophil elastase requires heparinR E Jordan, R M Nelson, J Kilpatrick, et al.
Circulation|May 20, 1998
Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockadeM A Mascelli, E T Lance, L Damaraju, et al.
NPJ Primary Care Respiratory Medicine|January 5, 2020
Accuracy of Vitalograph lung monitor as a screening test for COPD in primary careA P Dickens, D A Fitzmaurice, P Adab, et al.
Blood|August 1, 1996
Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human plateletsC L Wagner, M A Mascelli, D S Neblock, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Advances in Experimental Medicine and Biology|April 30, 2009
A synthetic peptide approach for elucidating the points of natural auto-antibody reactivity to proteolytic fragments of human IgGA Schmidt, D DeRiggi, R E Jordan, et al.
Biochemical Society Transactions|November 1, 1995
Anti-platelet monoclonal antibodies for the prevention of arterial thrombosis: experience with ReoPro, a monoclonal antibody directed against the platelet GPIIb/IIIa receptorH F Weisman, T F Schaible, R E Jordan, et al.
Advances in Experimental Medicine and Biology|January 1, 1977
Factors affecting the proteolytic degradation of elastinH M Kagan, R E Jordan, R M Lerch, et al.
The Journal of Biological Chemistry|June 25, 1989
Inactivation of human antithrombin by neutrophil elastase. Kinetics of the heparin-dependent reactionR E Jordan, R M Nelson, J Kilpatrick, et al.
American Heart Journal|March 31, 2000
Therapeutic heparin concentrations augment platelet reactivity: implications for the pharmacologic assessment of the glycoprotein IIb/IIIa antagonist abciximabM A Mascelli, N S Kleiman, S J Marciniak, et al.
Hepatology (Baltimore, Md.)|May 1, 1985
The immunologic diagnosis of chronic active "autoimmune" hepatitis: distinction from systemic lupus erythematosusL E Gurian, T M Rogoff, A J Ware, et al.
The American Journal of Medicine|September 11, 1989
Antithrombin inactivation by neutrophil elastase requires heparinR E Jordan, R M Nelson, J Kilpatrick, et al.
Circulation|May 20, 1998
Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockadeM A Mascelli, E T Lance, L Damaraju, et al.
NPJ Primary Care Respiratory Medicine|January 5, 2020
Accuracy of Vitalograph lung monitor as a screening test for COPD in primary careA P Dickens, D A Fitzmaurice, P Adab, et al.
Blood|August 1, 1996
Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human plateletsC L Wagner, M A Mascelli, D S Neblock, et al.
Pageof 12